Innate Pharma
IPHA
#8311
Rank
C$0.20 B
Marketcap
$2.56
Share price
5.22%
Change (1 day)
-21.65%
Change (1 year)

Earnings for Innate Pharma (IPHA)

Earnings in 2022: -C$86.55 Million

According to Innate Pharma 's latest financial reports the company's current earnings are C$53.18 Million. In 2022 the company made an earning of -C$86.55 Million a decrease over its 2021 earnings that were of -C$71.68 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innate Pharma from 2005 to 2022

Annual earnings

Year Earnings Change
2022-C$86.55 Million20.74%
2021-C$71.68 Million4951.09%
2020-C$1.42 Million-111.57%
2019C$12.26 M183.46%
2018C$4.32 M-105.4%
2017-C$80.18 Million-523.25%
2016C$18.94 M-285.64%
2015-C$10.21 Million-69.31%
2014-C$33.26 Million498.29%
2013-C$5.56 Million-5.62%
2012-C$5.89 Million-53.32%
2011-C$12.62 Million-50.1%
2010-C$25.29 Million-13.3%
2009-C$29.17 Million26.36%
2008-C$23.08 Million27.35%
2007-C$18.13 Million63.33%
2006-C$11.1 Million9.81%
2005-C$10.11 Million